Activist 13D/13G Filings - Enliven Therapeutics Inc. (ELVN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-11-14
5:48 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		Venrock Healthcare Capital Partners III L.P.4,026,331
8.500%		1,071,429increase
(+36.26%)		View
2024-11-14
5:46 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		RA CAPITAL MANAGEMENT L.P.1,061,233
2.200%		1,061,233increase
(New Position)		View
2024-11-14
4:24 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		CITADEL ADVISORS LLC1,734,094
3.700%		1,307,237increase
(+306.25%)		View
2024-11-14
4:15 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		Fairmount Funds Management LLC3,202,798
6.800%		1,071,429increase
(+50.27%)		View
2024-11-14
4:05 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		COMMODORE CAPITAL LP4,100,000
8.700%		1,198,184increase
(+41.29%)		View
2024-11-13
5:55 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		Polar Capital Holdings Plc2,687,797
5.690%		2,687,797increase
(New Position)		View
2024-11-08
2:17 pm
Unchanged		13GEnliven Therapeutics, Inc.
ELVN		BlackRock Inc.
BLK		2,936,642
6.200%		0
(Unchanged)		View
2024-10-24
2:02 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		BlackRock Inc.
BLK		2,936,642
6.200%		2,936,642increase
(New Position)		View
2024-07-29
6:12 pm
Sale		13DEnliven Therapeutics, Inc.
ELVN		5AM Ventures VI L.P.2,304,332
4.900%		-531,543decrease
(-18.74%)		View
2024-05-20
4:55 pm
Sale		13DEnliven Therapeutics, Inc.
ELVN		ORBIMED ADVISORS LLC7,918,163
16.800%		-1,033,300decrease
(-11.54%)		View
2024-04-15
7:21 pm
Sale		13DEnliven Therapeutics, Inc.
ELVN		5AM Ventures VI L.P.2,835,875
6.100%		-1,000,100decrease
(-26.07%)		View
2024-04-04
4:39 pm
Purchase		13DEnliven Therapeutics, Inc.
ELVN		ORBIMED ADVISORS LLC8,951,463
19.200%		2,124increase
(+0.02%)		View
2024-02-16
4:15 pm
Sale		13DEnliven Therapeutics, Inc.
ELVN		5AM Ventures VI L.P.3,835,975
9.300%		-825,000decrease
(-17.70%)		View
2024-02-14
8:53 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		Venrock Healthcare Capital Partners III L.P.2,954,902
7.200%		740,760increase
(+33.46%)		View
2024-02-14
4:58 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		CITADEL ADVISORS LLC2,394,448
5.800%		95,692increase
(+4.16%)		View
2024-02-14
4:05 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		COMMODORE CAPITAL LP2,901,816
7.000%		819,693increase
(+39.37%)		View
2024-02-14
3:45 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		Fairmount Funds Management LLC2,131,369
5.200%		6,744increase
(+0.32%)		View
2024-02-14
3:31 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		PFIZER INC
PFE		389,429
0.950%		389,429increase
(New Position)		View
2024-02-09
09:03 am
Purchase		13GEnliven Therapeutics, Inc.
ELVN		FMR CORP5,902,265
14.321%		1,482,684increase
(+33.55%)		View
2024-02-07
12:16 pm
Purchase		13GEnliven Therapeutics, Inc.
ELVN		Braden M Leonard50,000
0.100%		50,000increase
(New Position)		View
Goto 0, 1, 2, Next